Professional Documents
Culture Documents
Jos Manuel Ypiz Carrillo Jos Luis Martnez Prez Paul Enrique Lpez
UNIVERSIDAD DE SONORA
Licenciatura en Medicina
Human immunodeficiency virus (HIV) is a blood-borne virus typically transmitted via sexual intercourse, shared intravenous drug , and mother-to-child transmission (MTCT), which can occur during the birth process or during breastfeeding. HIV disease is caused by infection with HIV-1 or HIV2, which are retroviruses in the Retroviridae family, Lentivirus genus.
1981 Centers for Disease Control and Prevention (CDC) Unexplained appearance Pneumocystis Carinii, 1983 virus was isolated from patients with lymph nodes. 1984 It was found that the virus was the responsible agent of AIDS. 1985 development of a test that allowed realizing the scope and evolution of the epidemic infection.
Studies in the U.S. have identified five high-risk groups, distribution by cases: Homosexuality or bisexuality 50% of reported cases. IV Drug without history of homosexuality 20% Hemophiliacs, before 1985, 0.5% Blood transfusion, hemophiliacs, 1% Heterosexual contact, 10%
"Extensive studies indicate that HIV infection cannot be transmitted by personal contact. The spread by insect bites is impossible "
HIV disease is caused by infection with HIV-1 or HIV-2, both of which cause very similar conditions. They differ in transmission and progression risks. Human Retrovirus Family not transforming Lentivirus subfamily.
Two genetically distinct forms: - HIV-1 (USA, Europe, Central Africa) - HIV-2 (West Africa, India)
Morphology
Its a spherical particle of 0.1 microns The viral core (or capsid): is usually conical or bullet-shaped and is made from the protein p24. The viral envelope (or membrane): it's a lipid envelope derived from host cell membrane that surrounding the core.
Structures:
The matrix: Its just below the viral envelope, which is made from the protein p17 that cover the capsid directly.
Morphology
Components :
On the membrane Around 72 membrane complexes composed of gp120 and gp41: glycoproteins that protrude viral coat. That help HIV to enter the cell.
Viral Genetic
HIV is a retrovirus of the lentivirus subgroup.
HIV has just nine genes (compared to more than 500 genes in a bacterium, and around 20,000-25,000 in a human Structural genes: contain information needed to make structural proteins for new virus particles. gag. - Proteins of the capsid, RNA and matrix. pol. - reverse transcriptase, protease and Integrase. env. - surface membrane and transmembrane proteins.
Viral Genetic
Accessory genes:
General functions: 1) Code for proteins that control the ability of HIV to infect a cell 2) Produce new copies of virus 3) Cause disease How do they do? Synthesis and assembly product transactivators Efect: increase 1000 times viral gene transcription
Viral Genetic
Accessory genes:
Vif.- Encodes a protein associated to virus infectivity Tat.- Transactivator gene of proteins
Rev.- Regulator gene of the proteic exprecion viral Nef.- Negative regulator (not proved ) Vpr.- Accelerator of cycle gene transcription and protein synthesis Vpu.- Increases speeds of release virions (HIV-1 only)
Viral Genetic
At either end of each strand of RNA is a sequence called the long terminal repeat, which helps to control HIV replication.
Genomic variability Grouped into regions of the envelope glycoproteins, that is, in the env gene Subgroups M, O and N. Subtypes of Subgroup M are named as A - K.
Following transcription , the HIV mRNA is translated into proteins which are modified by glycosylation, myristylation, phosphorylation and cleavage .
The viral particle is formed by the assembly of proteins , enzymes and HIV genomic RNA in the membrane of the cell which formed the outer casing of immature viron . Protease ( coded by the virus before ) catalyzes the cleavage of gag-pol precursor to yield the mature virion
Cellular
Cytotoxic T lymphocytes.- HIV antigens induce exprecion of cytokines such as IFN-y and lysis of infected cells Proliferative cellular response.- Viral antigens induce the proliferation of CD8 cytotoxic lymphocytes and NK
Antibody dependent cellular cytotoxicity.When a phagocyte in contact with an infected cell or HIV, opsonized; released cytokines that collaborate in defense against infection
Humoral
Clinical manifestations
The clinical consequences of HIV infection encompass a spectrum ranging from an acute syndrome associated with primary infection to a prolonged asymptomatic state to advanced disease. It is best to regard HIV disease as beginning at the time of primary infection and progressing through various stages.
-Pharyngitis -Lymphadenopaty
- Headache /retroorbital pain - Arthralgias / myalgias -Anorexia - Nausea/ vomiting / diarrhea
During the asymptomatic period of HIV infection, the average rate of CD4+ T cell decline is 50/L per year. When the CD4+ T cell count falls to <200/L, the resulting state of immunodeficiency is severe enough to place the patient at high risk for opportunistic infection and neoplasms and, hence, for clinically apparent disease.
Symptomatic Disease
Symptoms of HIV disease can appear at any time during the course of HIV infection
Generally, the spectrum of illnesses that one observes changes as the CD4+ T cell count declines
The more severe and life-threatening complications of HIV infection occur in patients with CD4+ T cell counts <200/L
Diagnosis of AIDS is made in anyone with HIV infection and a CD4+ T cell count <200/L Indicate defect in cellmediated immunity
Diseases of respiratoy sistem Acute bronchitis and sinusitis Pulmonary disease (Pneumonia and TB) Fungal infections (coccidioides immitis and aspergillus) Neoplastic diseases (lymphoma)
Patients with HIV infection have higher levels of triglycerides, lower levels of high-density lipoprotein cholesterol
- Vulvovaginal candidiasis
Dermatologic diseases
- Folliculitis - Reactivation herpes zoster -Psoriasis -Seborrheic dermatitis
Neurologic diseases
- Toxoplasmosis - Cryptococcosis
-Trypanosomiasis - Peripheral neuropathies - Myopathy
-Lymphomas
- Burkitts lymphoma
immunosuppression.
DIAGNOSIS
Detection Procedure
Screening test: the presence of antibodies to HIV in serum
or plasma , as evidenced by one of the following methods : - linked immunosorbent assay ( ELISA ) - passive agglutination . Additional Tests: presence of HIV antibodies in serum or plasma. - blot ( Western blot test ) - Immunofluorescence - Radioimmunoprecipitation ( RIPA ) Additional tests to determine the presence of virus or any component - virus culture ; - determination of viral antigen ; - chain reaction of the polymerase, to determine the viral RNA or proviral DNA .
Diagnosis of infection
Detection in serum : Anti - HIV antibody ELISA test . With a sensitivity of 99.5 %. Detection of antibodies and p24 antigen are those with greater sensitivity.
When we do the study? When the person claims the study. Exposure to HIV infection unexplained Immunosuppression Pregnancy Son of a mother with HIV + Blood Donor
Confirmation: Western Blot: timely assessment of the specific reactivity of antibodies to different viral proteins.
Treatment
a) Find a combination of highly active antiretroviral drugs that are capable of removing virtually HIV-1 replication.